Defining the functional properties of GMP and whey protein study 2007

Phase 4

Completed

• Conditions: obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12607000331437
• Lead Sponsor: Commonwealth Scientific Industrial Research Organisation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

•Overweight or obese (BMI>25kg/m2) (This will be calculated for you based on your weight (kg) divided by your height in metres squared).•No recent history (past 3 months) of weight loss or changes to diet or physical activity routine.•Unrestrained eater (i.e. restrained eater questionnaire score >10)

Exclusion Criteria

•Type 1 or 2 Diabetes•Active liver and kidney disease as noted from medical questionnaire•Current gastrointestinal disease • Past history of gastrointestinal surgery which may affect study outcomes• Hypersensitivity to study foods (milk products)•Medications which affect GI motility or hunger /appetite (e.g.metoclopramide, domperidone and cisapride, anticholinergic drugs (eg atropine), erythromycin)•Unable to comprehend study protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Food intake[At 3 hours after drink]

Secondary Outcome Measures

Name	Time	Method
Glucose, insulin, appetite hormones.[At each visit at times 0, 15, 30, 60 90,120 and 180 minutes.]